Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base-Reference-Cited by-同舟云学术

Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base

Published:2014-04-16 Issue:5 Volume:114 Page:719-726
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Smith Angela B.¹²,Deal Allison M.²³,Woods Michael E.¹²,Wallen Eric M.¹²,Pruthi Raj S.¹²,Chen Ronald C.²⁴,Milowsky Matthew I.²⁵,Nielsen Matthew E.¹²⁵⁶

Affiliation:

1. Department of Urology; University of North Carolina at Chapel Hill; Chapel Hill NC USA

2. Lineberger Comprehensive Cancer Center; Multidisciplinary Genitourinary Oncology; Chapel Hill NC USA

3. Lineberger Comprehensive Cancer Center; Biostatistics and Clinical Data Management Core; University of North Carolina at Chapel Hill; Chapel Hill NC USA

4. Department of Radiation Oncology; University of North Carolina at Chapel Hill; Chapel Hill NC USA

5. Department of Medicine; Division of Hematology/Oncology; University of North Carolina at Chapel Hill; Chapel Hill NC USA

6. Department of Epidemiology; Gillings School of Global Public Health; University of North Carolina at Chapel Hill; Chapel Hill NC USA

Funder

National Institutes of Health

American Cancer Society

University Cancer Research Fund

Urology Care Foundation/ Astellas

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12601/fullpdf

Reference20 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

2. Clark PE Spiess PE Agarwal N NCCN Guidelines Version 1.2013: Bladder Cancer 2013 http://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf

3. Feasibility of radical transurethral resection as monotherapy for selected patients with muscle invasive bladder cancer;Solsona;J Urol,2010

4. Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population;Schrag;Urology,2005

5. Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer;Shipley;Urology,2002

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced nanomaterials in prognostic implication of oncogenic role of CDCA7 and GALNT6 for bladder cancer treatment;Journal of Radiation Research and Applied Sciences;2024-12

2. Immunohistochemical expression of GATA3, CK5/6 and CK20 in molecular subtypes of bladder carcinoma: correlation with clinicopathological features;Bulletin of the National Research Centre;2024-08-29

3. LIG1 is a novel marker for bladder cancer prognosis: evidence based on experimental studies, machine learning and single-cell sequencing;Frontiers in Immunology;2024-08-21

4. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO Guideline (2017; Amended 2020, 2024);Journal of Urology;2024-07

5. The Role of Semaphorin 6D (Sema6D) in Non-Muscle-Invasive Bladder Cancer—A Preliminary Study on Human Plasma and Urine;Biomedicines;2024-06-27